Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$, page-144

Holders should not feel ashamed to expect a commessurate rise in SP with progress. A mature board should understand this is a valid expectation. Some here try to villify people who question why the SP is floundering despite the apparent successes.

Yes in the event of a buyout it won't matter but that's not a valid reason to suggest it is not important now. When more patients pass the SP will be hit. If the phase 2 doesnt replicate phase 1 we will get hammered. A rise in SP along the way gives people opportunity to balance risk as well as shield the long termers from future bumps in the road, it also gives us a maximised springboard to launch from on ultimate success.

I for one am somewhat dissapointed in the new teams comms. Id say it is definitely poorer than prior to MT resigning and probably contributes largely to the SP.

Yes they are busy delivering the plan, but set aside time to manage the sp, to manage the comms etc. It does not have to be one without the other. In fact in the run to 50c we saw MT doing just this....he was doing it so well we all heralded his return. So far it appears to have been lacking in this front in comparison to prior....even with a bigger team.

Anyway PAA holders have been patient this long....what's another 12 months.